z-logo
open-access-imgOpen Access
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial
Author(s) -
Chris Parker,
Nicholas D. James,
Christopher D. Brawley,
Noel W. Clarke,
Adnan Ali,
Claire Amos,
Gerhardt Attard,
Simon Chowdhury,
Adrian Cook,
William Cross,
David P. Dearnaley,
Hassan Douis,
Duncan C. Gilbert,
Clare Gilson,
Silke Gillessen,
Alex Hoyle,
Robert J. Jones,
Ruth E. Langley,
Zafar Malik,
Malcolm D. Mason,
David Matheson,
Robin Millman,
Mary Rauchenberger,
Hannah Rush,
Martin Russell,
Hannah Sweeney,
Amit Bahl,
Alison Birtle,
Lisa Capaldi,
Omar Din,
Daniel Ford,
Joanna Gale,
Ann Henry,
Peter Hoskin,
M. Kagzi,
Anna Lydon,
Joe M. O’Sullivan,
Sangeeta Paisey,
Omi Parikh,
Delia Pudney,
Vijay Ramani,
Peter Robson,
Narayanan Srihari,
Jacob Tanguay,
Mahesh Parmar,
Matthew R. Sydes
Publication year - 2022
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.1003998
Subject(s) - medicine , prostate cancer , hazard ratio , proportional hazards model , quality of life (healthcare) , radiation therapy , oncology , cancer , confidence interval , nursing

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom